Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.
暂无分享,去创建一个
Josep Vidal | Violeta Moizé | A. Lacy | J. Vidal | M. Musri | R. Casamitjana | S. Delgado | Rosa Morínigo | Melina Musri | Antonio M Lacy | Salvador Navarro | José Luís Marín | Salvadora Delgado | Roser Casamitjana | V. Moizé | J. Marín | R. Morínigo | Salvador Navarro
[1] M. Nauck,et al. Glucagon‐like peptide 1(GLP‐1) in biology and pathology , 2005, Diabetes/metabolism research and reviews.
[2] P. Shekelle,et al. Meta-Analysis: Surgical Treatment of Obesity , 2005, Annals of Internal Medicine.
[3] M. Horowitz,et al. Gastric emptying after gastric bypass. , 1986, International journal of obesity.
[4] M. Bessler,et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. , 2005, The Journal of clinical endocrinology and metabolism.
[5] S. Woods,et al. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. , 2005, American journal of physiology. Endocrinology and metabolism.
[6] A. Stunkard,et al. Appetitive behavior after gastric bypass for obesity. , 1981, International journal of obesity.
[7] S. Toubro,et al. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety—effect of obesity and weight reduction , 2001, International Journal of Obesity.
[8] T. Reinehr,et al. Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss. , 2005, The Journal of clinical endocrinology and metabolism.
[9] V. Marks,et al. Attenuated GLP-1 secretion in obesity: cause or consequence? , 1996, Gut.
[10] S. Aylwin. Gastrointestinal surgery and gut hormones , 2005 .
[11] J. Holst,et al. Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity , 1997, International Journal of Obesity.
[12] Husebye,et al. Delay of gastric emptying by duodenal intubation: sensitive measurement of gastric emptying by the paracetamol absorption test , 1999, Alimentary pharmacology & therapeutics.
[13] J. Flier,et al. The Gut and Energy Balance: Visceral Allies in the Obesity Wars , 2005, Science.
[14] J. Saebel,et al. Eating Behavior and the Experience of Hunger Following Gastric Bypass Surgery for Morbid Obesity , 1997, Obesity surgery.
[15] I. Näslund,et al. Gastric emptying rate after gastric bypass and gastroplasty. , 1987, Scandinavian journal of gastroenterology.
[16] J. A. Fernández-Represa,et al. Peptide YY Secretion in Morbidly Obese Patients Before and After Vertical Banded Gastroplasty , 2002, Obesity surgery.
[17] R. Whelpton,et al. A model of gastric emptying using paracetamol absorption in intensive care patients , 1997, Intensive Care Medicine.
[18] A. Astrup,et al. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity , 2001, International Journal of Obesity.
[19] R. Batterham,et al. Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters , 2006, Annals of surgery.
[20] A. Lacy,et al. Short-term effects of gastric bypass surgery on circulating ghrelin levels. , 2004, Obesity research.
[21] E. Dellinger,et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. , 2002, The New England journal of medicine.
[22] Mohammad A Ghatei,et al. Inhibition of food intake in obese subjects by peptide YY3-36. , 2003, The New England journal of medicine.
[23] D. Martin,et al. Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. , 1990, Annals of surgery.
[24] R. Brolin,et al. Bariatric surgery and long-term control of morbid obesity. , 2002, JAMA.
[25] J. Dixon,et al. Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. , 2005, The Journal of clinical endocrinology and metabolism.
[26] Claude Bouchard,et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. , 2004, The New England journal of medicine.
[27] R. Zabielski,et al. Multiple regulation of peptide YY secretion in the digestive tract , 2002, Peptides.
[28] S. Woods,et al. Food intake and the regulation of body weight. , 2000, Annual review of psychology.
[29] G. Sciarretta,et al. Lactulose hydrogen breath test in orocecal transit assessment , 1994, Digestive Diseases and Sciences.
[30] G. Wittert,et al. Hormonal Changes after Roux-en Y Gastric Bypass for Morbid Obesity and the Control of Type-II Diabetes Mellitus , 2004, The American surgeon.
[31] M. Gagner,et al. The Early Effect of the Roux-en-Y Gastric Bypass on Hormones Involved in Body Weight Regulation and Glucose Metabolism , 2004, Annals of surgery.
[32] T. Adrian,et al. Release of peptide YY (PYY) after resection of small bowel, colon, or pancreas in man. , 1987, Surgery.
[33] Rachel L. Batterham,et al. Gut hormone PYY3-36 physiologically inhibits food intake , 2002, Nature.
[34] A. Astrup,et al. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.
[35] D. Cummings,et al. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. , 2004, The Journal of clinical endocrinology and metabolism.
[36] S. Bloom,et al. Why do patients lose weight after Roux-en-Y gastric bypass? , 2005, The Journal of clinical endocrinology and metabolism.
[37] E. Straus,et al. Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation. , 1986, International journal of obesity.